Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Stopped Study was terminated by Sponsor; the decision was not due to any safety findings.

Conditions

• RSV Infection

Interventions

• DRUG: Obeldesivir
• DRUG: Obeldesivir Placebo

Sponsor

Gilead Sciences